TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

References

• Farag YM Gaballa MR Diabesity: an overview of a rising epidemic Nephrol Dial Transplant 2011 26 28 35 21045078
   PubMed Web of Science ®Google Scholar
• Laakso M Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008 Diabetes Care 2010 33 442 449 20103560
   PubMed Web of Science ®Google Scholar
• Tschop MH DiMarchi RD Outstanding Scientific Achievement Award Lecture 2011: defeating diabesity. The case for personalized combinatorial therapies Diabetes 2012 61 1309 1314 22618765
   PubMed Web of Science ®Google Scholar
• Haslam D Obesity and diabetes: the links and common approaches Prim Care Diabetes 2010 4 105 112 20447884
   PubMed Web of Science ®Google Scholar
• Meigs JB Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009 Diabetes Care 2010 33 1865 1871 20668155
   PubMedGoogle Scholar
• Fruchart JC Sacks FM Hermans MP Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i) Curr Med Res Opin 2010 26 1793 1797 20482323
   PubMed Web of Science ®Google Scholar
• Hermans MP Fruchart JC Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians Ther Adv Chronic Dis 2011 2 307 323 23251757
   PubMedGoogle Scholar
• Nesto RW Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome Am J Cardiovasc Drugs 2005 5 379 387 16259526
   PubMedGoogle Scholar
• Varbo A Benn M Tybjaerg-Hansen A Jorgensen AB Frikke-Schmidt R Nordestgaard BG Remnant cholesterol as a causal risk factor for ischemic heart disease J Am Coll Cardiol 2013 61 427 436 23265341
   PubMed Web of Science ®Google Scholar
• Fruchart JC Sacks FM Hermans MP The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient Diab Vasc Dis Res 2008 5 319 335 18958843
   PubMed Web of Science ®Google Scholar
• Watanabe M Houten SM Mataki C Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation Nature 2006 439 484 489 16400329
   PubMed Web of Science ®Google Scholar
• Maruyama T Miyamoto Y Nakamura T Identification of membrane-type receptor for bile acids (M-BAR) Biochem Biophys Res Commun 2002 298 714 719 12419312
   PubMed Web of Science ®Google Scholar
• Thomas C Gioiello A Noriega L TGR5-mediated bile acid sensing controls glucose homeostasis Cell Metab 2009 10 167 177 19723493
   PubMed Web of Science ®Google Scholar
• Svensson PA Olsson M Andersson-Assarsson JC The TGR5 gene is expressed in human subcutaneous adipose tissue and is associated with obesity, weight loss and resting metabolic rate Biochem Biophys Res Commun 2013 433 563 566 23523790
   PubMed Web of Science ®Google Scholar
• Pols TW Nomura M Harach T TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading Cell Metab 2011 14 747 757 22152303
   PubMed Web of Science ®Google Scholar
• Kawamata Y Fujii R Hosoya M A G protein-coupled receptor responsive to bile acids J Biol Chem 2003 278 9435 9440 12524422
   PubMed Web of Science ®Google Scholar
• Katsuma S Hirasawa A Tsujimoto G Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1 Biochem Biophys Res Commun 2005 329 386 390 15721318
   PubMed Web of Science ®Google Scholar
• Wu T Bound MJ Standfield SD Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans Diabetes Obes Metab 2013 15 474 477 23181598
   PubMed Web of Science ®Google Scholar
• Keitel V Donner M Winandy S Kubitz R Haussinger D Expression and function of the bile acid receptor TGR5 in Kupffer cells Biochem Biophys Res Commun 2008 372 78 84 18468513
   PubMed Web of Science ®Google Scholar
• Ugawa T Kakuta H Moritani H Shikama H Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model Br J Pharmacol 2002 135 1572 1578 11906972
   PubMed Web of Science ®Google Scholar
• Li G Liu X Zhu H Insulin resistance in insulin-resistant and diabetic hamsters (Mesocricetus auratus) is associated with abnormal hepatic expression of genes involved in lipid and glucose metabolism Comp Med 2009 59 449 458 19887029
   PubMed Web of Science ®Google Scholar
• Nabeno-Kaeriyama Y Fukuchi Y Hayashi S Kimura T Tanaka A Naito M Delayed postprandial metabolism of triglyceride-rich lipoproteins in obese young men compared to lean young men Clin Chim Acta 2010 411 1694 1699 20621072
   PubMed Web of Science ®Google Scholar
• Pruneta-Deloche V Sassolas A Linga-Thie GM Berthezene F Ponsin G Moulin P Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes J Lipid Res 2004 45 859 865 14967813
   PubMed Web of Science ®Google Scholar
• Tornvall P Olivecrona G Karpe F Hamsten A Olivecrona T Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins Arterioscler Thromb Vasc Biol 1995 15 1086 1093 7627700
   PubMed Web of Science ®Google Scholar
• Bansal S Buring JE Rifai N Mora S Sacks FM Ridker PM Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 2007 298 309 316 17635891
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG Benn M Schnohr P Tybjaerg-Hansen A Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 2007 298 299 308 17635890
   PubMed Web of Science ®Google Scholar
• Havel RJ Postprandial hyperlipidemia and remnant lipoproteins Curr Opin Lipidol 1994 5 102 109 8044412
   PubMedGoogle Scholar
• Gupta R Guptha S Agrawal A Kaul V Gaur K Gupta VP Secular trends in cholesterol lipoproteins and triglycerides and prevalence of dyslipidemias in an urban Indian population Lipids Health Dis 2008 7 40 18950504
   PubMed Web of Science ®Google Scholar
• Zoppini G Negri C Stoico V Casati S Pichiri I Bonora E Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus Metabolism 2012 61 22 29 21676418
   PubMed Web of Science ®Google Scholar